PLoS ONE (Jan 2013)

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.

  • Nikola A Bowden,
  • Katie A Ashton,
  • Ricardo E Vilain,
  • Kelly A Avery-Kiejda,
  • Ryan J Davey,
  • Heather C Murray,
  • Timothy Budden,
  • Stephen G Braye,
  • Xu Dong Zhang,
  • Peter Hersey,
  • Rodney J Scott

DOI
https://doi.org/10.1371/journal.pone.0070424
Journal volume & issue
Vol. 8, no. 8
p. e70424

Abstract

Read online

Nucleotide excision repair (NER) orchestrates the repair of helix distorting DNA damage, induced by both ultraviolet radiation (UVR) and cisplatin. There is evidence that the global genome repair (GGR) arm of NER is dysfunctional in melanoma and it is known to have limited induction in melanoma cell lines after cisplatin treatment. The aims of this study were to examine mRNA transcript levels of regulators of GGR and to investigate the downstream effect on global transcript expression in melanoma cell lines after cisplatin treatment and in melanoma tumours. The GGR regulators, BRCA1 and PCNA, were induced in melanocytes after cisplatin, but not in melanoma cell lines. Transcripts associated with BRCA1, BRCA2, ATM and CHEK2 showed altered expression in melanoma cell lines after cisplatin treatment. In melanoma tumour tissue BRCA1 transcript expression correlated with poor survival and XPB expression correlated with solar elastosis levels. Taken together, these findings provide evidence of the mechanisms underlying NER deficiency in melanoma.